Turnstone Biologics Corp. (TSBX)

NASDAQ: TSBX · Real-Time Price · USD

0.4100

-0.0010 (-0.24%)

Mar 31, 2025, 10:46 AM EDT - Market open

Turnstone Biologics Employees

Turnstone Biologics had 80 employees as of December 31, 2023. The number of employees decreased by 28 or -25.93% compared to the previous year.

Employees

80

Change (1Y)

-28

Growth (1Y)

-25.93%

Revenue / Employee

n/a

Profits / Employee

-$885,463

Market Cap

9.48M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	80	-28	-25.93%
Dec 31, 2022	108	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

TSBX News

2 days ago - Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
5 months ago - Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire
8 months ago - Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study - Benzinga
8 months ago - Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
8 months ago - Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer - GlobeNewsWire
11 months ago - Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
11 months ago - Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference - GlobeNewsWire
1 year ago - Turnstone Biologics Appoints William Waddill to its Board of Directors - GlobeNewsWire